Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
9.33
-0.96 (-9.33%)
At close: Oct 23, 2026, 4:00 PM EDT
9.30
-0.03 (-0.32%)
Pre-market: Oct 26, 2026, 7:03 AM EDT
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $154.7 million as of October 23, 2026. It is the 22,232nd most valuable company in the world and the 3,769th biggest in the United States. Its market cap has increased by 57.38% in one year.
Market Cap
154.70M
Enterprise Value
1.14M
1-Year Change
57.38%
Global Rank
Country Rank
#3,769 United States
Category
ChartMarket Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has decreased from $336.80M to $154.70M, a decrease of -54.07%. That is a compound annual growth rate of -9.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 154.70M | 57.06% |
| Dec 31, 2025 | 98.50M | -35.07% |
| Dec 31, 2024 | 151.70M | -41.99% |
| Dec 29, 2023 | 261.50M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -17.85% |
| Dec 31, 2020 | 838.10M | 229.96% |
| Dec 31, 2019 | 254.00M | 23.24% |
| Dec 31, 2018 | 206.10M | -38.81% |
| Sep 27, 2018 | 336.80M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sionna Therapeutics | 162.76M |
| Adagene | 161.82M |
| ALX Oncology Holdings | 161.78M |
| Entrada Therapeutics | 159.01M |
| NovaBridge Biosciences | 158.92M |
| Coherus Oncology | 156.05M |
| MediWound | 154.92M |
| NervGen Pharma | 153.76M |